


The Fund aims to provide a high level of income together with long term capital growth.
| Name | % Net Assets | 
|---|---|
| GlaxoSmithKline PLC | 4.0% | 
| Diageo PLC | 3.7% | 
| Babcock International Group PLC | 3.2% | 
| Cable & Wireless PLC | 2.8% | 
| Smith & Nephew PLC | 2.8% | 
| Unilever PLC | 2.6% | 
| Melrose PLC | 2.5% | 
| Chemring Group PLC | 2.2% | 
| VT Group PLC | 2.2% | 
| Reed Elsevier PLC | 2.2% | 
| Key | % Net Assets | 
|---|---|
| 4.0% | |
| 3.7% | |
| 3.2% | |
| 2.8% | |
| 86.3% | 
| Date | 18-Jun-2025 | 
|---|---|
| NAV | 174.50p | 
| Currency | GBP | 
| Change | -4.10p | 
| % | -2.30% | 
| YTD change | 11.70p | 
| YTD % | 7.19% | 
| Fund Inception | 06/05/2005 | 
|---|---|
| Fund Manager | Matt Hudson | 
| TER | 1.23 (30-Apr-2011) | 
| Minimum Investment | |
|---|---|
| Initial | £25000 | 
| Additional | £500 | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | n/a | 
| Annual Mang't | 1.00% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.01 | 
| Sharpe ratio | 0.07 | 
You are here: research